BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17709604)

  • 1. Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis.
    Chaligné R; James C; Tonetti C; Besancenot R; Le Couédic JP; Fava F; Mazurier F; Godin I; Maloum K; Larbret F; Lécluse Y; Vainchenker W; Giraudier S
    Blood; 2007 Nov; 110(10):3735-43. PubMed ID: 17709604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
    Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
    Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
    Wang X; Haylock D; Hu CS; Kowalczyk W; Jiang T; Qiu J; Mosoyan G; He W; Marshall N; Mascarenhas J; Tarasova A; Brody J; Winkler D; Hoffman R
    Blood; 2016 Jun; 127(26):3398-409. PubMed ID: 27114459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition.
    Chaligné R; Tonetti C; Besancenot R; Roy L; Marty C; Mossuz P; Kiladjian JJ; Socié G; Bordessoule D; Le Bousse-Kerdilès MC; Vainchenker W; Giraudier S
    Leukemia; 2008 Aug; 22(8):1557-66. PubMed ID: 18528423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells.
    Matsuoka Y; Takahashi M; Sumide K; Kawamura H; Nakatsuka R; Fujioka T; Sonoda Y
    Cell Transplant; 2017 Jun; 26(6):1043-1058. PubMed ID: 27938494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
    Glembotsky AC; Korin L; Lev PR; Chazarreta CD; Marta RF; Molinas FC; Heller PG
    Eur J Haematol; 2010 May; 84(5):398-405. PubMed ID: 20113333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation-negative chronic myeloproliferative disorders detected by a newly developed RQ-PCR based on TaqMan MGB probes.
    Ruan GR; Jiang B; Li LD; Niu JH; Li JL; Xie M; Qin YZ; Liu YR; Huang XJ; Chen SS
    Hematol Oncol; 2010 Mar; 28(1):33-9. PubMed ID: 19274616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
    Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl.
    Abdel-Azim H; Zhu Y; Hollis R; Wang X; Ge S; Hao QL; Smbatyan G; Kohn DB; Rosol M; Crooks GM
    Blood; 2008 Apr; 111(8):4064-74. PubMed ID: 18174381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
    Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
    Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of Signaling Events Downstream of the c-Mpl Receptor in Murine Hematopoietic Stem Cells Via Motif-Engineered Chimeric Receptors.
    Saka K; Lai CY; Nojima M; Kawahara M; Otsu M; Nakauchi H; Nagamune T
    Stem Cell Rev Rep; 2018 Feb; 14(1):101-109. PubMed ID: 28948469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPLW515L mutation in acute megakaryoblastic leukaemia.
    Hussein K; Bock O; Theophile K; Schulz-Bischof K; Porwit A; Schlue J; Jonigk D; Kreipe H
    Leukemia; 2009 May; 23(5):852-5. PubMed ID: 19194467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
    Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
    PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates.
    Debili N; Robin C; Schiavon V; Letestu R; Pflumio F; Mitjavila-Garcia MT; Coulombel L; Vainchenker W
    Blood; 2001 Apr; 97(7):2023-30. PubMed ID: 11264167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of MPL W515L/K mutations in patients with primary myelofibrosis and essential thrombocythaemia by allele-specific polymerase chain reaction.
    Daly S; Conneally E; Langabeer SE
    Acta Haematol; 2009; 121(4):221-2. PubMed ID: 19521067
    [No Abstract]   [Full Text] [Related]  

  • 18. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
    Besancenot R; Roos-Weil D; Tonetti C; Abdelouahab H; Lacout C; Pasquier F; Willekens C; Rameau P; Lecluse Y; Micol JB; Constantinescu SN; Vainchenker W; Solary E; Giraudier S
    Blood; 2014 Sep; 124(13):2104-15. PubMed ID: 25143485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of multi-lineage hematopoiesis during HIV-1 infection by human c-mpl gene transfer and reconstitution of CD34+ progenitor cells in vivo.
    Zhang M; Poh TY; Louache F; Sundell IB; Yuan J; Evans S; Koka PS
    J Stem Cells; 2009; 4(3):161-77. PubMed ID: 20232601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.